Global Lifestyle Drugs Market 2017-2021

ライフスタイル・ドラッグ(生活改善薬)の世界市場2017-2021

◆タイトル:Global Lifestyle Drugs Market 2017-2021
◆商品コード:IRTNTR11351
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年2月13日
◆ページ数:91
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:世界
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥371,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥477,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥530,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、ライフスタイル・ドラッグ(生活改善薬)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、ライフスタイル・ドラッグ(生活改善薬)の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Lifestyle Drugs MarketLifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity.

Technavio’s analysts forecast the global lifestyle drugs market to grow at a CAGR of 2.87% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global lifestyle drugs market for 2017-2021. To calculate the market size, the report considers sales of lifestyle drugs in the market.

The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC

Technavio’s report, Global Lifestyle Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Allergan
• BMS
• Eli Lilly
• Pfizer

[Other prominent vendors]
• Acerus Pharmaceuticals
• Alkermes
• Amorepacific
• AndroScience
• Anterios
• AstraZeneca
• Avanir Pharmaceuticals
• Avolynt
• Celtaxsys
• Cerecor
• Corcept Therapeutics
• Cosmo Pharmaceuticals
• CTC Bio
• Dermira
• Dong-A ST
• Euthymics Bioscience
• Foamix
• Follicum
• Forendo Pharma
• Futura Medical Developments
• Galderma
• Hanmi Pharmaceutical
• Incyte
• Intrepid Therapeutics
• Ion Channel Innovations
• iX Biopharma
• Johnson & Johnson
• Legacy Healthcare
• LEO Pharma
• H. Lundbeck
• Luye America Pharmaceuticals
• Merck
• Minerva Neurosciences
• MSI Methylation Sciences
• Neuralstem
• Novan
• Novartis
• Novo-Nordisk
• Palatin Technologies
• Paratek Pharmaceuticals
• Photocure
• Revance Therapeutics
• Rhythm Pharmaceuticals
• S1 Biopharma
• Sage Therapeutics
• Samumed
• Sanofi
• Sigma-Tau Pharmaceuticals
• Strategic Science & Technologies
• Sumitomo Dainippon Pharma
• Takeda
• TetraLogic Pharmaceuticals
• TherapeuticsMD
• Valeant Pharmaceuticals
• VistaGen Therapeutics
• VIVUS
• XBiotech
• Yuhan
• Zafgen

[Market driver]
• Lifestyle changes
• For a full, detailed list, view our report

[Market challenge]
• Patent expiries
• For a full, detailed list, view our report

[Market trend]
• Increase in M&A
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: An overview of lifestyle diseases

PART 06: Market landscape

Market overview
Five forces analysis

PART 07: Pipeline landscape

PART 08: Market segmentation by therapy area

Depression
Dermatology (acne, anti-aging, and baldness)
Sexual dysfunction
Obesity

PART 09: Geographical segmentation

Lifestyle drugs market in Americas
Lifestyle drugs market in EMEA
Lifestyle drugs market in APAC

PART 10: Market drivers

Lifestyle changes
Development of novel therapeutics
Increasing demand from older population

PART 11: Impact of drivers

PART 12: Market challenges

Patent expiries
Side effects coupled with product recalls
Presence of alternative therapies and treatments

PART 13: Impact of drivers and challenges

PART 14: Market trends

Increase in M&A
Growing focus on development of drugs for new indications
Emerging lifestyle diseases

PART 15: Vendor landscape

Competitive scenario

PART 16: Key vendor analysis

Allergan
BMS
Eli Lilly
Pfizer
Other prominent vendors

PART 17: Appendix

List of abbreviation

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Global lifestyle drugs market snapshot

Exhibit 02: Global lifestyle drugs market 2016-2021 ($ billions)

Exhibit 03: Opportunity analysis in global lifestyle drugs market

Exhibit 04: Five forces analysis

Exhibit 05: Pipeline analysis of vendors in Phase III

Exhibit 06: Key pipeline drugs for depression 2016

Exhibit 07: Key pipeline drugs for dermatology (anti-aging, baldness, and acne) 2016

Exhibit 08: Key pipeline drugs for sexual dysfunction 2016

Exhibit 09: Key pipeline drugs for obesity

Exhibit 10: Global depression drugs market 2016-2021 ($ billions)

Exhibit 11: Global dermatology lifestyle drugs market 2016-2021 ($ billions)

Exhibit 12: Global sexual dysfunction drugs market 2016-2021 ($ billions)

Exhibit 13: Global obesity drugs market 2016-2021 ($ billions)

Exhibit 14: Segmentation of global lifestyle drugs market by geography 2016 and 2021

Exhibit 15: Global lifestyle drugs market revenue by geography 2016-2021 ($ billions)

Exhibit 16: Market scenario in Americas

Exhibit 17: Lifestyle drugs market in Americas 2016-2021 ($ billions)

Exhibit 18: Market scenario in EMEA

Exhibit 19: Lifestyle drugs market in EMEA 2016-2021 ($ billions)

Exhibit 20: Market scenario in APAC

Exhibit 21: Lifestyle drugs market in APAC 2016-2021 ($ billions)

Exhibit 22: Impact of drivers

Exhibit 23: Impact of drivers and challenges

Exhibit 24: Competitive structure analysis of global lifestyle drugs market 2016

Exhibit 25: Competitive analysis of global lifestyle drugs market

Exhibit 26: Market penetration of various lifestyle drug manufacturers worldwide 2016

Exhibit 27: Strategic success factors of companies in global lifestyle drugs market

Exhibit 28: Allergan: Key highlights

Exhibit 29: Allergan: Strength assessment

Exhibit 30: Allergan: Strategy assessment

Exhibit 31: Allergan: Opportunity assessment

Exhibit 32: BMS: Strength assessment

Exhibit 33: BMS: Strategy assessment

Exhibit 34: BMS: Opportunity assessment

Exhibit 35: BMS: YoY and growth rate of Abilify 2013-2015 ($ billions)

Exhibit 36: Eli Lilly: Key highlights

Exhibit 37: Eli Lilly: Strength assessment

Exhibit 38: Eli Lilly: Strategy assessment

Exhibit 39: Eli Lilly: Opportunity assessment

Exhibit 40: Eli Lilly: YoY and growth rate of Cymbalta 2013-2015 ($ millions)

Exhibit 41: Eli Lilly: YoY and growth rate of Zyprexa 2013-2015 ($ millions)

Exhibit 42: Eli Lilly: YoY and growth rate of Strattera 2013-2015 ($ millions)

Exhibit 43: Eli Lilly: YoY and growth rate of Cialis 2013-2015 ($ millions)

Exhibit 44: Pfizer: Key highlights

Exhibit 45: Pfizer: Strength assessment

Exhibit 46: Pfizer: Strategy assessment

Exhibit 47: Pfizer: Opportunity assessment

Exhibit 48: Pfizer: YoY and growth rate of Pristiq 2013-2015 ($ millions)

Exhibit 49: Pfizer: YoY and growth rate of Zoloft 2013-2015 ($ millions)

Exhibit 50: Pfizer: YoY and growth rate of Effexor 2013-2015 ($ millions)

Exhibit 51: Pfizer: YoY and growth rate of Viagra 2013-2015 ($ millions)



【資料のキーワード】

ライフスタイルドラッグ、生活改善薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[ライフスタイル・ドラッグ(生活改善薬)の世界市場2017-2021] (Global Lifestyle Drugs Market 2017-2021 / IRTNTR11351)販売に関する免責事項
[ライフスタイル・ドラッグ(生活改善薬)の世界市場2017-2021] (Global Lifestyle Drugs Market 2017-2021 / IRTNTR11351)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆